Whereas KP enzymes preceding KMO, and also the 2 Trp transporters SLC1A5 and SLC7A5, are up-regulated in 32-46% of cancer types, KMO and subsequent enzymes show lesser expression, ranging from 3 to 18% (Figure 4). This evidence concerns the gene KMO and cancer.